Stacey D. Stewart Elected to Hologic Board of Directors

Your unfiltered news center. ®

The world you see depends upon the news you get. ®

HOME

ARTS

RSS

Today's Date: April 23, 2024

Slimbook Fedora 2: New Ultrabooks for Fedora Linux 40 • Gameto Partners with Designer and Entrepreneur Stacey Bendet to Launch "Your Eggsperience Matters" Campaign to Raise Funds for R • Petsense by Tractor Supply Announces Spring Adoption Event to Help Shelter Animals Find Forever Homes • EvolutionIQ Unveils MedHub: Revolutionizing Medical Synthesis within Claims Guidance Ecosystem • St. Croix Hospice Director of Education Receives 2024 Memory Care Innovation Awards • Minister Champagne highlights budget investments in Indigenous reconciliation • NET Power Schedules First Quarter 2024 Earnings Release and Conference Call • Anaergia Announces Additional Delay in the Filing of Its Audited Financial Statements and Related Disclosures • Alto-Shaam - Restaurants are losing up to $26,000 to food waste, research reveals • Amid the Nation's Ongoing Youth Mental Health Crisis, New Research Shows the Critical Role Sports Can Play in Promoting Girls' M • Could the Housing Market Be Turning Around For Buyers? Some Prospective Homebuyers Think So • Level Up Mom’s Day with Epic Savings at T-Mobile • Age of Learning Named One of TIME's Top EdTech Companies of 2024 • Vibrantz Technologies releases its first corporate social responsibility report • EMPOWERING WOMEN: pH-D FEMININE HEALTH'S COMMITMENT TO VAGINAL WELLNESS • Lygos Takes Aim at Multi-Billion Dollar Personal Care Industry with SoltellusTM • GoPro Adds Eight Young 'Stars of Tomorrow' to its Professional Athlete Team • PDP Celebrates Fortnite Festival Season 3 With the Launch of the RIFFMASTER Wireless Guitar Controller • Finalists announced for CJF Jackman Excellence Award • Pitney Bowes Named ‘Best Employer for Diversity’ by Forbes for Sixth Consecutive Year

Stacey D. Stewart Elected to Hologic Board of Directors

MARLBOROUGH, Mass. , December 09 /Businesswire/ - Hologic, Inc. (Nasdaq: HOLX) announced today that Stacey D. Stewart has been elected to the Company’s Board of Directors, effective January 2, 2023. Ms. Stewart was also appointed to the Audit and Finance Committee effective January 2, 2023.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20221209005067/en/

Stacey D. Stewart (Photo: Business Wire)

Ms. Stewart has served as President and CEO of March of Dimes Inc., a leading non-profit organization, since November 2016. As previously announced, Ms. Stewart is expected to step down from March of Dimes at the end of this calendar year. Prior to March of Dimes, Ms. Stewart served in a variety of executive positions, from June 2009 to November 2016, including U.S. President of operations and executive vice president for Community Impact Leadership and Learning at United Way Worldwide, the world's largest charitable organization.

“It is a pleasure to welcome Stacey to our Board,” said Steve MacMillan, Hologic’s Chairman, President and Chief Executive Officer. “With her experience leading purpose-driven organizations and extensive background in finance, she brings additional depth to the operational expertise of our Board, along with valuable knowledge and perspective on healthcare, policy, and health equity.”

Ms. Stewart holds a Bachelor of Arts in economics from Georgetown University and a Master of Business Administration from the University of Michigan.

About Hologic, Inc.

Hologic, Inc. is an innovative medical technology company primarily focused on improving women's health and well-being through early detection and treatment. For more information on Hologic, visit www.hologic.com.

Forward Looking Statements

This press release contains forward-looking information that involves risks and uncertainties, including statements about the Company's plans, objectives, expectations and intentions, and statements regarding the Company's Board of Directors. These forward-looking statements are based on assumptions made by the Company as of this date and are subject to known and unknown risks and uncertainties that could cause actual results to differ materially from those anticipated. These risks include, but are not limited to, the risk that the Company may not be able to attract and retain qualified Board members or executives. These risks are not exhaustive. Other factors that could adversely affect the Company's business and prospects are described in the filings made by the Company with the SEC. The Company expressly disclaims any obligation or undertaking to release publicly any updates or revisions to any such statements presented here to reflect any change in expectations or any change in events, conditions or circumstances on which any such statements are based.

SOURCE: Hologic, Inc.